Pharmacy Benefit Managers: Do They Provide the Value Promised?

被引：0

作者：

Mirda, Daniel P. ^{[1
]}

机构：

[1] Annadel St Joseph Hlth Med Grp, 2 Huntington Ct, Napa, CA 94558 USA

来源：

JCO ONCOLOGY PRACTICE | 2020年 / 16卷 / 05期

关键词：

D O I：

10.1200/OP.20.00194

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：273 / +

页数：3

共 50 条

[31] Pharmacy Benefit Managers and Their Obligations During Serious Prescription Drug Shortages
Teagarden, J. R.
Epstein, R. S.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (02) : 143 - 145
[32] Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?
Cohen, Joshua P.
El Khoury, Christelle
Milne, Christopher-Paul
Peters, Sandra M.
HEALTH SERVICES RESEARCH, 2018, 53 : 2758 - 2769
[33] DO TRADE SHOWS PROVIDE VALUE
SASHI, CM
PERRETTY, J
INDUSTRIAL MARKETING MANAGEMENT, 1992, 21 (03) : 249 - 255
[34] DO VALUE-BASED AGREEMENTS FOR PHARMACEUTICALS PROVIDE ADDITIONAL ECONOMIC BENEFIT TO THE US HEALTH SYSTEM?
Ali, O.
Meads, A.
Merryfield, N.
VALUE IN HEALTH, 2021, 24 : S91 - S91
[35] Why do antioxidants fail to provide clinical benefit?
Ascan Warnholtz
Thomas Münzel
Trials, 1 (1)
[36] Pharmacy benefit managers' role in facilitating medicare beneficiary access to pharmaceutical care
Cohen, J
Chee, J
DISEASE MANAGEMENT & HEALTH OUTCOMES, 2002, 10 (04) : 221 - 227
[37] Comparing Pharmacy Benefit Managers: Moving Well Beyond the Simple Spreadsheet Analysis
Calabrese, David
AMERICAN HEALTH AND DRUG BENEFITS, 2008, 1 (05): : 9 - 19
[38] Biosimilar Competition In The United States: Statutory Incentives, Payers, And Pharmacy Benefit Managers
Falit, Benjamin P.
Singh, Surya C.
Brennan, Troyen A.
HEALTH AFFAIRS, 2015, 34 (02) : 294 - 301
[39] The Hypocrisy of Many Pharmacy Benefit Managers: "Pay No Attention to That Man Behind the Curtain"
Del Rosso, James Q.
JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (06) : 598 - 599
[40] How Pharmacy Benefit Managers Add to Financial Toxicity The Copay Accumulator Program
Nabhan, Chadi
Phillips, Eli G., Jr.
Feinberg, Bruce A.
JAMA ONCOLOGY, 2018, 4 (12) : 1665 - 1666

← 1 2 3 4 5 →